PRESS DT TABLET contains Acetazolamide, which belongs to the group of medicines called Carbonic Anhydrase Inhibitors. It is used in the management of glaucoma, retention of fluids in the body, and epilepsy (fits). Glaucoma is a condition of the eyes that can result in loss of vision and blindness by damaging a nerve in the back of the eye called the optic nerve.
Before starting with the management, your doctor may advise you to undergo some blood tests to check if management with PRESS DT TABLET is suitable for you. Tell your doctor if you are due to have any medical tests, as PRESS DT TABLET may interfere with these tests.
Before taking PRESS DT TABLET, inform your doctor if you have or ever had severe kidney, liver, or lung problems, chronic non-congestive angle closure glaucoma, reduced function of adrenal glands (Addison’s disease), low sodium/potassium levels, or high chlorine levels in the blood.
PRESS DT TABLET is not recommended for use in pregnancy and should be taken with consultation of a doctor during breastfeeding. In children and adolescents, the correct dose of PRESS DT TABLET will be decided by the doctor, according to the patient’s body weight.
A small number of people being managed with medicines like PRESS DT TABLET have had thoughts of harming or killing themselves. If you experience anything like that, immediately contact your doctor. The most common side effects of taking PRESS DT TABLET are extreme tiredness, nausea, vomiting, stomach pain, and diarrhea. Consult your physician if any of the symptoms worsen over time.
No content available
